•  
  •  
 

Abstract

Background: Spinal anesthesia during cesarean sections is associated with a number of common problems, including postoperative nausea and vomiting (PONV), which can make the mother feel uneasy and negatively impact the perioperative results. The neuraxial adjuvant dexmedetomidine has shown promise since it is a very selective α₂- adrenergic receptor agonist that can improve spinal anesthesia and also provide extra sedative and anti-shivering effects. Objective:To evaluate the effect of adding 5μg intrathecal dexmedetomidine to hyperbaric bupivacaine on the incidence of shivering and PONV during elective cesarean section. Patients and Methods: Elective caesarean sections under spinal anesthesia were elective for 100 healthy parturients in this prospective randomized controlled experiment. Two equal groups, each with fifty participants, were randomly allocated to the study. Patients in Group-A were given intrathecal hyperbaric bupivacaine without any other medication, while those in Group-B were given hyperbaric bupivacaine together with 5μg of dexmedetomidine. Monitoring hemodynamic indicators, evaluating sensory and motor block profiles, and documenting the incidence and intensity of shivering were all part of the perioperative examinations. The incidence of PONV was also documented. Results: Demographic information and intraoperative hemodynamic indicators did not differ significantly between the two groups. There was a statistically significant difference in the time it took for sensory and motor block to begin and end in the dexmedetomidine group (P

Article Type

Original Study

Subject Area

Anaesthesiology

Creative Commons License

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.

Download

Share

COinS